Department of Clinical Neurophysiology, Aarhus University Hospital, Denmark.
Insitute of Neurology, Queen Square House, London, United Kingdom.
Neurophysiol Clin. 2022 Apr;52(2):157-169. doi: 10.1016/j.neucli.2021.11.002. Epub 2021 Dec 11.
To assess the inter-rater reliability of MScanFit MUNE using a "Round Robin" research design.
Twelve raters from different centres examined six healthy study participants over two days. Median, ulnar and common peroneal nerves were stimulated, and compound muscle action potential (CMAP)-scans were recorded from abductor pollicis brevis (APB), abductor digiti minimi (ADM) and anterior tibial (TA) muscles respectively. From this we calculated the Motor Unit Number Estimation (MUNE) and "A50", a motor unit size parameter. As statistical analysis we used the measures Limits of Agreement (LOA) and Coefficient of Variation (COV). Study participants scored their perception of pain from the examinations on a rating scale from 0 (no pain) to 10 (unbearable pain).
Before this study, 41.6% of the raters had performed MScanFit less than five times. The mean MUNE-values were: 99.6 (APB), 131.4 (ADM) and 126.2 (TA), with LOA: 19.5 (APB), 29.8 (ADM) and 20.7 (TA), and COV: 13.4 (APB), 6.3 (ADM) and 5.6 (TA). MUNE-values correlated to CMAP max amplitudes (R-values were: 0.463 (APB) (p<0.001), 0.421 (ADM) (p<0.001) and 0.645 (TA) (p<0.001)). The average perception of pain was 4.
MScanFit indicates a high level of inter-rater reliability, even with only limited rater experience and is overall reasonably well tolerated by patients. These results may indicate MScanFit as a reliable MUNE method with potential as a biomarker in drug trials.
使用“轮替”研究设计评估 MScanFit MUNE 的观察者间可靠性。
来自不同中心的 12 名评估者在两天内检查了 6 名健康的研究参与者。刺激正中神经、尺神经和腓总神经,分别从拇短展肌(APB)、小指展肌(ADM)和胫骨前肌(TA)记录复合肌肉动作电位(CMAP)-扫描。由此我们计算了运动单位数量估计(MUNE)和“A50”,一个运动单位大小参数。作为统计分析,我们使用了测量协议范围(LOA)和变异系数(COV)。研究参与者使用从 0(无痛)到 10(无法忍受的疼痛)的评分量表对检查过程中的疼痛感知进行评分。
在这项研究之前,41.6%的评估者进行 MScanFit 的次数少于 5 次。平均 MUNE 值为:99.6(APB)、131.4(ADM)和 126.2(TA),LOA 为:19.5(APB)、29.8(ADM)和 20.7(TA),COV 为:13.4(APB)、6.3(ADM)和 5.6(TA)。MUNE 值与 CMAP max 幅度相关(R 值分别为:0.463(APB)(p<0.001)、0.421(ADM)(p<0.001)和 0.645(TA)(p<0.001))。平均疼痛感知为 4。
MScanFit 表明具有高度的观察者间可靠性,即使评估者经验有限,并且总体上患者耐受性良好。这些结果可能表明 MScanFit 是一种可靠的 MUNE 方法,具有作为药物试验生物标志物的潜力。